Fairmount Funds Management LLC

Holdings History for Apogee Therapeutics, Inc. - COMMON STOCK (APGE)

Symbol: APGE on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 6,047,027 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Peter Evan Harwin ownership in Apogee Therapeutics, Inc. COMMON STOCK (APGE)

22 Jan 2026 - Peter Evan Harwin has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,047,027 shares of Apogee Therapeutics, Inc. COMMON STOCK (APGE). This represents 10% ownership of the company. In their previous filing dated 14 Oct 2025, Fairmount Funds Management LLC had reported owning 5,776,881 shares, indicating an increase of +4.7%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Peter Evan Harwin	10%	0%	$456,430,807	6,047,027	+270,146	+4.7%	$75.48	13D/A	22 Jan 2026	22 Jan 2026, 20:00
Peter Evan Harwin	10%		$229,515,482	5,776,881			$39.73	13D/A	10 Oct 2025	14 Oct 2025, 19:11

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	12%	0%	$154,631,876	2,048,647	0		$75.48	Q4 2025
30 Sep 2025	7.3%	0%	$81,392,745	2,048,647	0		$39.73	Q3 2025
30 Jun 2025	12%	0%	$88,972,739	2,048,647	0		$43.43	Q2 2025
31 Mar 2025	12%	0%	$76,537,452	2,048,647	0		$37.36	Q1 2025
31 Dec 2024	9.2%	0%	$92,803,709	2,048,647	0		$45.30	Q4 2024
30 Sep 2024	9.8%	0%	$120,337,525	2,048,647	0		$58.74	Q3 2024
30 Jun 2024	9.1%	0%	$80,614,259	2,048,647	0		$39.35	Q2 2024
31 Mar 2024	15%	-6.5%	$136,132,593	2,048,647	-892,529	-30%	$66.45	Q1 2024
31 Dec 2023	8.7%	0%	$82,176,457	2,941,176	0		$27.94	Q4 2023
30 Sep 2023	7.5%	+7.5%	$62,647,049	2,941,176	+2,941,176	NEW	$21.30	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.